Cargando…

Non-selective beta blocker use is associated with improved short-term survival in patients with cirrhosis referred for liver transplantation

BACKGROUND: Recent evidence cautions against the use of non-selective beta-blockers (NSBB) in patients with refractory ascites or spontaneous bacterial peritonitis while other data suggests a survival benefit in patients with advanced liver disease. The aim of this study was to describe the use and...

Descripción completa

Detalles Bibliográficos
Autores principales:	Ngwa, Taiwo, Orman, Eric, Gomez, Eduardo Vilar, Vuppalanchi, Raj, Kubal, Chandrashekhar, Chalasani, Naga, Ghabril, Marwan
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2020
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6945622/ https://www.ncbi.nlm.nih.gov/pubmed/31906860 http://dx.doi.org/10.1186/s12876-019-1155-1

Ejemplares similares

Extra-hepatic comorbidity burden significantly increases 90-day mortality in patients with cirrhosis and high model for endstage liver disease
por: Coppel, Scott, et al.
Publicado: (2020)

Sex disparities in waitlisting and liver transplant for acute liver failure
por: Nephew, Lauren D., et al.
Publicado: (2020)

Comorbidity Burden May Be Associated with Increased Mortality in Patients with Severe Acute Liver Injury Referred for Liver Transplantation
por: Steiner-Temnykh, Lindsey, et al.
Publicado: (2020)

Progressive Cholestasis and Biliary Cirrhosis After Initiating Oral Semaglutide: Report From the Drug-Induced Liver Injury Network
por: Ma, Jiayi, et al.
Publicado: (2022)

Association of State Medicaid Expansion With Racial/Ethnic Disparities in Liver Transplant Wait-listing in the United States
por: Nephew, Lauren D., et al.
Publicado: (2020)

Trends in Characteristics, Mortality, and Other Outcomes of Patients With Newly Diagnosed Cirrhosis
por: Orman, Eric S., et al.
Publicado: (2019)

Liver Transplantation in Recipients With Class III Obesity: Posttransplant Outcomes and Weight Gain
por: Soma, Daiki, et al.
Publicado: (2022)

Racial Disparities in Liver Transplantation for Hepatocellular Carcinoma Are Not Explained by Differences in Comorbidities, Liver Disease Severity, or Tumor Burden
por: Dakhoul, Lara, et al.
Publicado: (2018)

Neighborhood poverty is associated with failure to be waitlisted and death during liver transplantation evaluation
por: Mohamed, Kawthar A., et al.
Publicado: (2022)

Early predictors of outcomes of hospitalization for cirrhosis and assessment of the impact of race and ethnicity at safety-net hospitals
por: Mukthinuthalapati, V. V. Pavan Kedar, et al.
Publicado: (2019)

Trends in Racial and Ethnic Disparities in the Receipt of Lifesaving Procedures for Hospitalized Patients With Decompensated Cirrhosis in the US, 2009-2018
por: Nephew, Lauren D., et al.
Publicado: (2023)

Serum Hepcidin Levels Are Associated With Obesity but Not Liver Disease
por: Vuppalanchi, Raj, et al.
Publicado: (2013)

4295 The Impact of Social Determinants of Health on Hepatocellular Carcinoma Outcomes
por: Nephew, Lauren Devore, et al.
Publicado: (2020)

Contemporary Trends in Hospitalizations for Comorbid Chronic Liver Disease and Substance Use Disorders
por: Desai, Archita P., et al.
Publicado: (2021)

Severe Alcohol‐Associated Hepatitis Is Associated With Worse Survival in Critically Ill Patients With Acute on Chronic Liver Failure
por: Patidar, Kavish R., et al.
Publicado: (2021)

Significant Medical Comorbidities Are Associated With Lower Causality Scores in Patients Presenting With Suspected Drug-Induced Liver Injury
por: Ghabril, Marwan, et al.
Publicado: (2020)

Beta-blockers in liver cirrhosis
por: Giannelli, Valerio, et al.
Publicado: (2014)

MELD–Na Is More Strongly Associated with Risk of Infection and Outcomes Than Other Characteristics of Patients with Cirrhosis
por: Fricker, Zachary P., et al.
Publicado: (2020)

Treatment of Idiosyncratic Drug-Induced Liver Injury Using Steroids
por: Sundaram, Suneha, et al.
Publicado: (2020)

HIV-1 Coinfection Profoundly Alters Intrahepatic Chemokine but Not Inflammatory Cytokine Profiles in HCV-Infected Subjects
por: Hu, Sishun, et al.
Publicado: (2014)

Social determinants of health impact mortality from HCC and cholangiocarcinoma: a population-based cohort study
por: Nephew, Lauren D., et al.
Publicado: (2023)

Development and Validation of a Model to Predict Acute Kidney Injury in Hospitalized Patients With Cirrhosis
por: Patidar, Kavish R., et al.
Publicado: (2019)

Hepatic steatosis is highly prevalent but is not correlated with stiffness in autoimmune hepatitis
por: Chalasani, Sai, et al.
Publicado: (2020)

HLA-DR Mismatch and Black Race Are Associated With Recurrent Autoimmune Hepatitis After Liver Transplantation
por: McCabe, Marshall, et al.
Publicado: (2021)

Relationship between Differential Hepatic microRNA Expression and Decreased Hepatic Cytochrome P450 3A Activity in Cirrhosis
por: Vuppalanchi, Raj, et al.
Publicado: (2013)

Beta-blockers in cirrhosis: Evidence-based indications and limitations
por: Rodrigues, Susana G., et al.
Publicado: (2019)

Beta-blockers in patients with liver cirrhosis: Pragmatism or perfection?
por: Sauerbruch, Tilman, et al.
Publicado: (2023)

Incidence and Risk Factors of Recurrent Clostridioides difficile Infection in Patients With Cirrhosis
por: Phatharacharukul, Parkpoom, et al.
Publicado: (2020)

Removal of medicaid restrictions were associated with increased hepatitis C virus treatment rates, but disparities persist
por: Nephew, Lauren D., et al.
Publicado: (2022)

Outcomes of Acute Respiratory Distress Syndrome in Mechanically Ventilated Patients With Cirrhosis
por: Boente, Ryan D., et al.
Publicado: (2019)

Blunted cardiovascular effects of beta-blockers in patients with cirrhosis: Relation to severity?
por: Nabilou, Puria, et al.
Publicado: (2022)

Bleeding After Elective Interventional Endoscopic Procedures in a Large Cohort of Patients With Cirrhosis
por: Kundumadam, Shanker, et al.
Publicado: (2020)

Impact of Recipient Age in Combined Liver-Kidney Transplantation: Caution Is Needed for Patients ≥70 Years
por: Ekser, Burcin, et al.
Publicado: (2020)

Serum high mobility group box 1 protein levels are not associated with either histological severity or treatment response in children and adults with nonalcoholic fatty liver disease
por: Yates, Katherine P., et al.
Publicado: (2017)

Nonselective beta-blocker use is associated with increased hepatic encephalopathy-related readmissions in cirrhosis
por: Fallahzadeh, Mohammad Amin, et al.
Publicado: (2022)

Longer time to recovery from acute kidney injury is associated with major adverse kidney events in patients with cirrhosis
por: Patidar, Kavish R., et al.
Publicado: (2023)

A composite score using quantitative magnetic resonance cholangiopancreatography predicts clinical outcomes in primary sclerosing cholangitis
por: Vuppalanchi, Raj, et al.
Publicado: (2023)

Non-selective beta-blockers and the incidence of hepatocellular carcinoma in patients with cirrhosis: a meta-analysis
por: He, Xinyi, et al.
Publicado: (2023)

Treatment with non‐selective beta‐blockers affects the systemic inflammatory response to bacterial DNA in patients with cirrhosis
por: Gimenez, Paula, et al.
Publicado: (2018)

Beta‐blockers for hypertension
por: Wiysonge, Charles S, et al.
Publicado: (2017)

Cannot write session to /tmp/vufind_sessions/sess_mmmfqd55fjsmu3qsdmkf9rf1u9